Researchers examined the efficacy of the quadrivalent vaccine Gardasil in 3,819 women aged 24 to 45 years who had no history of genital warts or cervical disease.
The efficacy against disease or infection related to the four HPV types was 90 per cent.
No serious adverse events related to the vaccine's use were reported in the study.
The researchers said the results demonstrated that susceptible women 24 to 45 years of age could benefit from vaccination.
'Our results are generalisable to women aged 24 to 45 years in the general population who have had no (recent) cervical disease and no previous history of external genital disease,' they said.
Comment below and tell us what you think